A detailed history of Eagle Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Capital Management, LLC holds 126,154 shares of PFE stock, worth $3.6 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
126,154
Previous 126,004 0.12%
Holding current value
$3.6 Million
Previous $3.5 Million 0.94%
% of portfolio
1.56%
Previous 1.57%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$25.26 - $29.6 $3,789 - $4,440
150 Added 0.12%
126,154 $3.53 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $27,339 - $31,394
1,056 Added 0.85%
126,004 $3.5 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $3.26 Million - $4.24 Million
124,948 New
124,948 $3.6 Million
Q3 2019

Oct 15, 2019

SELL
$32.49 - $42.13 $2.75 Million - $3.57 Million
-84,677 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $41,602 - $46,710
1,125 Added 1.35%
84,677 $3.67 Million
Q1 2019

Apr 18, 2019

SELL
$37.5 - $41.2 $17,062 - $18,746
-455 Reduced 0.54%
83,552 $3.55 Million
Q4 2018

Jan 15, 2019

SELL
$38.47 - $43.86 $17,157 - $19,561
-446 Reduced 0.53%
84,007 $3.67 Million
Q3 2018

Oct 12, 2018

BUY
$34.47 - $41.81 $40,433 - $49,043
1,173 Added 1.41%
84,453 $3.72 Million
Q2 2018

Jul 19, 2018

BUY
$32.98 - $35.16 $11,015 - $11,743
334 Added 0.4%
83,280 $3.02 Million
Q1 2018

Apr 09, 2018

SELL
$31.91 - $37.02 $24,825 - $28,801
-778 Reduced 0.93%
82,946 $2.94 Million
Q4 2017

Jan 19, 2018

SELL
$33.26 - $35.29 $8,813 - $9,351
-265 Reduced 0.32%
83,724 $3.03 Million
Q3 2017

Oct 16, 2017

BUY
$31.0 - $34.15 $2.6 Million - $2.87 Million
83,989
83,989 $3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eagle Capital Management, LLC Portfolio

Follow Eagle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Capital Management, LLC with notifications on news.